Invitae Corporation
NVTA
Rankning i aktier
#35705
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aktiekurs
$0.016
Senast synkroniserad: 2024-03-11
Marknadsvärde
$3.27M
Förändring (1 dag)
-5.33%
Förändring (1 år)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)
Kategori
Healthcare
Aktiekurshistorik för Invitae Corporation (NVTA)
Högsta slutkurs: $0.00 den 2024-08-01
Lägsta slutkurs: $19.17 den 2015-02-01
Lägsta slutkurs: $19.17 den 2015-02-01
Aktiekurshistorik för Invitae Corporation från 2015 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
